This review aims to give an overview of the known polymorphisms ( Cholesteryl Ester Transfer Protein polymorphism , Stromelysin-1 polymorphism , -455G/A and TaqI polymorphisms of the beta-fibrinogen gene , apoE4 , Asp(9)Asn mutation in the lipoprotein lipase gene , the -514 CT polymorphism in the hepatic lipase gene and the ACE deletion type gene ) that have an influence on the effects of statins in the general population .